2m 2m 2m 2m 2m 2m 2m
PROFUSA (PFSA)
NASDAQ
$0.16-$0.005 (-3.33%)
Price as of Jun 23, 2026 8:00 PM EDT- $756,827.00Market Cap
- N/A1-Year Change
- Medical DevicesIndustry
PROFUSA (PFSA)
$0.16-$0.005 (-3.33%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | 11.9M +32.74% | 8.9M +2,486.98% | |
Cost of Revenue | N/A N/A | 1.4M -10.45% | 1.5M +18.74% | 1.3M N/A | |
Gross Profit | 0 +100.00% | -1.4M -113.05% | 10.4M +35.06% | 7.7M +2,119.22% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -2.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 27.7M +1,950.72% | 1.4M -10.45% | 1.5M +18.74% | 1.3M +86.95% | |
Operating Profit | -27.7M +1,950.72% | -1.4M -10.45% | -1.5M +18.74% | -1.3M +2,720.51% | |
Interest Income | N/A N/A | 425,416 -81.08% | 2.2M -12.82% | 2.6M +39,820.57% | |
Interest Expense | -1.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -1.3M -412.64% | 425,416 -81.08% | 2.2M -12.82% | 2.6M +39,820.57% | |
Total Nonoperating Income and Expense | -8.1M +11.50% | -7.3M -332.78% | 3.1M N/A | N/A N/A | |
Income before Taxes | -27.7M +221.00% | -8.6M -633.21% | 1.6M -78.89% | 7.7M +17,119.89% | |
Income Taxes | -5.5M -6,967.21% | 80,513 -82.37% | 456,790 -8.50% | 499,211 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -35.8M +311.21% | -8.7M -849.77% | 1.2M -83.79% | 7.2M +2,285.80% | |
Net Income from Continuing Operations Applicable to Common | -35.8M +315.05% | -8.6M -633.21% | 1.6M -78.89% | 7.7M +2,451.97% | |
Basic EPS and Net Income | -107.01 +7,179.59% | -1.47 -1,325.00% | 0.12 -60.00% | 0.30 +400.00% | |
Diluted EPS and Net Income | -107.01 +7,179.59% | -1.47 -1,325.00% | 0.12 -60.00% | 0.30 +400.00% | |
Basic Weighted Average Shares | 334,762 -55.22% | 747,644 -85.60% | 5.2M 0.00% | 5.2M +603.45% | |
Diluted Weighted Average Shares | 334,762 -55.22% | 747,644 -85.60% | 5.2M 0.00% | 5.2M +24.65% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.8M +10,872.60% | 16,204 +258.57% | 4,519 -97.66% | 193,486 -73.90% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.8M +10,872.60% | 16,204 +258.57% | 4,519 -97.66% | 193,486 -73.90% | |
Total Current Assets | 3.8M +6,084.48% | 60,862 -96.14% | 1.6M +208.06% | 511,704 -53.42% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 8,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 3,000 -99.96% | 8.3M -23.38% | 10.9M -94.40% | 194.2M +1.34% | |
Total Assets | 3.8M -55.02% | 8.4M -22.90% | 10.9M -94.41% | 194.7M +0.87% | |
Income Taxes Payable | 2.0M +3.83% | 1.9M -2.38% | 1.9M +316.82% | 462,271 N/A | |
Total Short-Term Debt | 5.5M -37.72% | 8.9M +843.53% | 944,118 +3,676.47% | 25,000 +1,449.91% | |
Total Current Liabilities | 22.3M +80.74% | 12.3M +150.23% | 4.9M +425.94% | 935,751 +778.55% | |
Total Long-Term Debt | 400,000 -79.16% | 1.9M +103.34% | 944,118 +372.06% | 200,000 0.00% | |
Total Long-Term Liabilities | 298,000 -57.19% | 696,170 +278.43% | 183,961 +398.00% | 36,940 -99.49% | |
Total Liabilities | 30.4M +133.90% | 13.0M +155.53% | 5.1M +178.17% | 1.8M -75.00% | |
Retained Earnings | -160.8M +1,140.86% | -13.0M +274.51% | -3.5M +458.04% | -619,995 -89.51% | |
Total Stockholders Equity | -26.7M +105.75% | -13.0M +274.55% | -3.5M +458.43% | -619,476 -89.52% | |
Total Shares Outstanding | 1.2M -76.96% | 5.3M +2.98% | 5.2M 0.00% | 5.2M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -16.2M +1,152.92% | -1.3M -37.20% | -2.1M +255.28% | -581,189 -12.26% | |
Capital Expenditures | 8,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -2.0M -167.66% | 3.0M -98.40% | 185.6M +554,807.51% | 33,447 +100.02% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 19.8M +1,295.73% | -1.7M -99.10% | -183.7M N/A | N/A N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | 87.28% +1.75% | 85.78% N/A | |
Operating Margin | N/A N/A | N/A N/A | -12.72% -10.55% | -14.22% N/A | |
Return on Assets | -588.87% +551.50% | -90.39% -8,098.10% | 1.13% -69.43% | 3.70% N/A | |
Return on Equity | 180.86% +70.40% | 106.14% +286.29% | -56.97% -74.05% | -219.58% N/A | |
Revenue Growth | N/A N/A | N/A N/A | 32.74% -98.68% | 2,486.98% N/A | |
Current Ratio | 0.17 +3,351.02% | 0.005 -98.47% | 0.32 -41.42% | 0.55 N/A | |
Cash Ratio | 0.08 +6,046.15% | 0.001 +44.44% | 0.0009 -99.56% | 0.21 N/A | |
Debt-to-Equity Ratio | -0.22 -73.30% | -0.84 +53.11% | -0.55 +50.28% | -0.36 N/A | |
Debt-to-Assets Ratio | 1.58 +22.11% | 1.29 +643.69% | 0.17 +14,358.33% | 0.001 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow